Skip to main content
Clinical Trials/NL-OMON27551
NL-OMON27551
Completed
Not Applicable

An open, randomized, (out-patient-) clinical study into the effectiveness, durability and cost efficiency of Tiscover (cultured, autologous skin) for chronic leg wounds (ulcera cruris).

WO-Biopartner First Stage Grant0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ulcera cruris venosa, ulcera cruris arterio(lo)scleroticum and ulcers of mixed origin
Sponsor
WO-Biopartner First Stage Grant
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
WO-Biopartner First Stage Grant

Eligibility Criteria

Inclusion Criteria

  • 1\. Ulcus cruris venosum, ulcus cruris arterio(lo)scleroticum and ulcers of mixed origin;
  • 2\. Non\-vital ulcers which exist for at least 5 months and which do not respond to adequate compression therapy and local wound treatment;

Exclusion Criteria

  • 1\. Diabetic foot ulcers;
  • 2\. Serious co\-morbidity which decreases the life expectancy to less than 2 years;

Outcomes

Primary Outcomes

Not specified

Similar Trials